Investors believe the platform could become the standard in personalized health analysis. Its insights help users understand long-term risks. The valuation reflects rising demand for preventive AI tools.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
